언론에 비친 KCS
후원사 혜택 안내
지면 광고 안내
소개 및 활동/사업
역대 학회상 수상자
대한화학회 창립 75주년
현재 가능한 작업은 아래와 같습니다.
09월 23일 17시 이후 : 초록수정 불가능, 일정확인 및 검색만 가능
제126회 대한화학회 학술발표회 및 총회
Metabolomics in human disease : advances and applications
2020년 9월 28일 09시 58분 16초
이곳을 클릭하시면 발표코드에 대한 설명을 보실 수 있습니다.
화 14시 : 30분
Analytical Chemistry -
Recent Advances in Mass Spectrometry based on Immunoaffinity
Korea Basic Science Institute, Korea
The development of global metabolic profiling and the study of the metabolomics are particularly important in human disease where small molecules such as endogenous metabolites play fundamental signaling roles. Metabolomic approaches not only can help unravel the underlying molecular mechanism of disease but also identify the signature of pathway characteristic for specific disease that can be used for diagnosis, prognosis, and targeted therapy. Therefore, metabolomics-drived approaches have the potential to map biochemical changes in disease and provide an opportunity to unveil the metabolic pathways. This approach can also improve our understanding of the biological processes that are associated with a certain phenotype and also allow studying how the dysregulation of specific biological pathways is propagated across the biological system.
Analytical platforms, including NMR and Mass spectrometry, were used to generate a molecular fingerprint of biofluid or tissue samples, and then pattern recognition technique was applied to identify molecular signatures associated with the specific diseases or drug efficiency. Several metabolites that differentiate disease samples from the control were thoroughly characterized and the metabolic changes in human and animal model were investigated using analytical platforms. Spectral data were applied to targeted profiling and spectral binning method, and then multivariate statistical data analysis (MVDA) was used to examine in detail the modulation of small molecule candidate biomarkers. The metabolomic profiling process generates accurate metabolite concentration data, and provides data that can be used to help understand metabolic differences between healthy and disease or drug treated models. Such metabolic signatures could provide diagnostic markers for a disease state or biomarkers for drug response phenotypes, and mechanistic information on cellular perturbations and pathways associated with diseases.
등록된 그림이 있는경우 그림을 클릭하시면 원본 그림파일을 볼 수 있습니다.
최종본을 확인하지 않아 발생된 문제에 대해서는 책임지지 않습니다.
미리보기의 그림위치는 임시 위치입니다. 모든 그림파일은 Abstract 하단에 위치하게 됩니다.